Hypoglycemic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice

被引：0
|
作者：
Inoue, T
Yoshitomi, H
Kasai, S
Hihara, T
Matsuura, F
Shinoda, M
Saeki, T
Tanaka, I
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A129 / A129
页数：1
相关论文
共 50 条
  • [41] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONIST AS A NOVEL TREATMENT FOR INTERSTITIAL CYSTITIS: A RAT MODEL
    Comiter, C.
    Dobberfuhl, A.
    Mahal, A.
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S272 - S273
  • [42] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONIST AS A NOVEL TREATMENT FOR INTERSTITIAL CYSTITIS: A RAT MODEL
    Comiter, Craig
    Younglin, Nichole
    Mahal, Aman
    Dobberfuhl, Amy
    JOURNAL OF UROLOGY, 2019, 201 (04): : E692 - E692
  • [43] The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
    Stunes, Astrid K.
    Westbroek, Irene
    Gustafsson, Bjorn I.
    Fossmark, Reidar
    Waarsing, Jan H.
    Eriksen, Erik F.
    Petzold, Christiane
    Reseland, Janne E.
    Syversen, Unni
    BMC ENDOCRINE DISORDERS, 2011, 11
  • [44] The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
    Astrid K Stunes
    Irene Westbroek
    Björn I Gustafsson
    Reidar Fossmark
    Jan H Waarsing
    Erik F Eriksen
    Christiane Petzold
    Janne E Reseland
    Unni Syversen
    BMC Endocrine Disorders, 11
  • [45] Amelioration of progressive renal injury by peroxisome proliferator-activated receptor-gamma (PPARγ) agonist in aging rats
    Yang, H-C
    Ma, L-J
    Fogo, A. B.
    LABORATORY INVESTIGATION, 2008, 88 : 297A - 297A
  • [46] Amelioration of progressive renal injury by peroxisome proliferator-activated receptor-gamma (PPARγ) agonist in aging rats
    Yong, H-C
    Ma, L-J
    Fogo, A. B.
    MODERN PATHOLOGY, 2008, 21 : 297A - 297A
  • [47] Effects of peroxisome proliferator-activated receptor (PPAR)delta agonist on sternohyoid muscle in MS model rats
    Shi, M.
    Zhang, L.
    Diao, X.
    Wang, J.
    Hao, J.
    Bi, X.
    SLEEP MEDICINE, 2015, 16 : S197 - S197
  • [48] Food does not affect the pharmacokinetics of tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist
    Samuelsson, S.
    Johansson, S.
    Halldorsdottir, S.
    Stenhoff, H.
    Ohman, K. P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1017 - 1022
  • [49] Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARα) agonist Wy14,643
    Zahradka, Peter
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (02): : 99 - 122
  • [50] Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice
    Ernst, Matthew C.
    Sinal, Christopher J.
    Pollak, P. Timothy
    PHARMACOLOGICAL RESEARCH, 2010, 62 (05) : 408 - 415
12345